Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
RDHL

RedHill Biopharma

$5.70

-0.21 (-3.55%)

07:25
11/22/19
11/22
07:25
11/22/19
07:25
Conference/Events
RedHill Biopharma to host investor & analyst day »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

RDHL

RedHill Biopharma

$6.02

-0.06 (-0.99%)

09:23
11/20/19
11/20
09:23
11/20/19
09:23
Conference/Events
RedHill Biopharma to host investor & analyst day »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

RDHL

RedHill Biopharma

$6.08

-0.17 (-2.72%)

07:08
11/19/19
11/19
07:08
11/19/19
07:08
Hot Stocks
RedHill Biopharma to complete enrollment for Yeliva study in 'coming months' »

The ongoing Phase 2a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 22

    Nov

RDHL

RedHill Biopharma

$6.08

-0.17 (-2.72%)

07:07
11/19/19
11/19
07:07
11/19/19
07:07
Hot Stocks
RedHill Biopharma 'working toward' confirmatory Phase 3 study for BEKINDA »

RedHill concluded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 22

    Nov

RDHL

RedHill Biopharma

$6.08

-0.17 (-2.72%)

07:06
11/19/19
11/19
07:06
11/19/19
07:06
Hot Stocks
RedHill Biopharma to initiate Phase 3 study activities with RHB-204 in 1H20 »

In light of supportive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 22

    Nov

RDHL

RedHill Biopharma

$6.08

-0.17 (-2.72%)

07:05
11/19/19
11/19
07:05
11/19/19
07:05
Hot Stocks
Breaking Hot Stocks news story on RedHill Biopharma »

RedHill Biopharma expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 22

    Nov

RDHL

RedHill Biopharma

$6.08

-0.17 (-2.72%)

07:04
11/19/19
11/19
07:04
11/19/19
07:04
Hot Stocks
Breaking Hot Stocks news story on RedHill Biopharma »

RedHill Biopharma expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 22

    Nov

RDHL

RedHill Biopharma

$6.08

-0.17 (-2.72%)

07:03
11/19/19
11/19
07:03
11/19/19
07:03
Earnings
RedHill Biopharma reports Q3 EPS (3c), consensus (38c) »

Reports Q3 revenue $1.4M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 22

    Nov

RDHL

RedHill Biopharma

$6.16

-0.06 (-0.96%)

08:06
11/15/19
11/15
08:06
11/15/19
08:06
Hot Stocks
RedHill Biopharma to voluntarily delist from Tel-Aviv Stock Exchange »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 22

    Nov

Over a month ago
RDHL

RedHill Biopharma

$6.34

-0.53 (-7.71%)

07:55
11/12/19
11/12
07:55
11/12/19
07:55
Hot Stocks
RedHill Biopharma announces publication of results of Phase 3 study of RHB-102 »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.